{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:48:58Z","timestamp":1794534538670,"version":"4.9.1"},"reference-count":42,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2022,11,2]]},"DOI":"10.1080\/03007995.2022.2100652","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T07:36:48Z","timestamp":1657784208000},"page":"1797-1806","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Comparative efficacy and safety of two insulin aspart formulations (Rapilin and NovoRapid) when combined with metformin, for patients with diabetes mellitus: a multicenter, randomized, open-label, controlled clinical trial"],"prefix":"10.1080","volume":"38","author":[{"given":"Jun","family":"Yao","sequence":"first","affiliation":[{"name":"Peking University First Hospital, Xicheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Guo","sequence":"additional","affiliation":[{"name":"Peking University First Hospital, Xicheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[{"name":"Siping Central Hospital, Siping, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Han","sequence":"additional","affiliation":[{"name":"Shengjing Hospital Affiliated to China Medical University, Tiexi District, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Lv","sequence":"additional","affiliation":[{"name":"Chinese People's Liberation Army General Hospital of Beijing Military Region, No. 5, South Gate Warehouse, Dongcheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuzhen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Tongji Hospital Affiliated to Tongji University, Putuo District, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Mo","sequence":"additional","affiliation":[{"name":"Third Xiangya Hospital of Central South University, Yuelu District, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Yang","sequence":"additional","affiliation":[{"name":"China-Japan Friendship Hospital, Sakura Garden, Chaoyang District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Zhang","sequence":"additional","affiliation":[{"name":"The second hospital of Hebei Medical University, Xinhua District, Shijiazhuang City, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanjian","family":"Wang","sequence":"additional","affiliation":[{"name":"The third hospital of Hebei Medical University, Qiaoxi District, Shijiazhuang City, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lvyun","family":"Zhu","sequence":"additional","affiliation":[{"name":"Bethune Peace Hospital, Qiaoxi District, Shijiazhuang City, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanmin","family":"Li","sequence":"additional","affiliation":[{"name":"The PLA Second Artillery General Hospital, Xicheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[{"name":"Jiangsu Province Hospital, Gulou District, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Wang","sequence":"additional","affiliation":[{"name":"Peking University Shougang Hospital, Shijingshan District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoming","family":"Xue","sequence":"additional","affiliation":[{"name":"Southern Medical University Nanfang Hospital, 1838, Baiyun District, Guangzhou City, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongquan","family":"Shi","sequence":"additional","affiliation":[{"name":"Shanghai Changzheng Hospital, Huangpu District, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juming","family":"Lu","sequence":"additional","affiliation":[{"name":"The General Hospital of the People's Liberation Army, Haidian District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongde","family":"Peng","sequence":"additional","affiliation":[{"name":"Shanghai General Hospital, Hongkou District, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Peking University Shenzhen Hospital, Futian District, Shenzhen City, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewen","family":"Yan","sequence":"additional","affiliation":[{"name":"The Second People's Hospital of Shenzhen, Futian District, Shenzhen City, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damei","family":"Wang","sequence":"additional","affiliation":[{"name":"Gan & Lee Pharmaceuticals Co Ltd, Huoxian, Tongzhou District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Yu","sequence":"additional","affiliation":[{"name":"Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Qiao Estuary Hankou, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843"},{"key":"CIT0002","unstructured":"Yiwei H. China's diabetes epidemic in charts CGTN.com: CGTN2019. [updated 14 November 2020; cited 2020 September 2, 2021]. Available from: https:\/\/news.cgtn.com\/news\/2019-11-14\/China-s-diabetes-epidemic-in-charts-LC60vrsOv6\/index.html."},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-S009"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200161110-00008"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2019.1689313"},{"key":"CIT0006","unstructured":"U.S. Food and Drug Administration. NovoLog: full prescribing information. [cited 2020 Aug 26]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020986s057lbl.pdf2008."},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050618"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0500-0"},{"issue":"1","key":"CIT0009","first-page":"4","volume":"10","author":"Diabetes Branch of Chinese Medical Association","year":"2018","journal-title":"Chin J Diabetes Mellitus"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.17925\/EE.2017.13.01.21"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2007.02.010"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-013-0026-y"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2006.0018"},{"key":"CIT0014","doi-asserted-by":"crossref","unstructured":"Plum-M\u00f6rschel L, Uhrmacher E, Zijlstra E, et\u00a0al. Proposed Biosimilar Gan & Lee Insulin Aspart (GL-ASP) shows Pharmacokinetic (PK) and Pharmacodynamic (PD) Bioequivalence (BE) To US- And EUlicensed Insulin Aspart (ASP). EASD Virtual Meeting; 2021.","DOI":"10.2337\/db21-738-P"},{"key":"CIT0015","unstructured":"European Medicines Agency. NovoRapid: summary of product information. [cited 2020 Aug 26]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/novorapid-epar-product-information_en.pdf2019."},{"key":"CIT0016","unstructured":"Su L. Reducing the China \u201cDrug Lag\u201d: 2017 CFDA Metrics. [cited 2021 Feb 4]. Available from: https:\/\/globalforum.diaglobal.org\/issue\/april-2018\/reducing-the-china-drug-lag-2017-cfda-metrics\/2018."},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2019.1570220"},{"issue":"1","key":"CIT0018","first-page":"1","volume":"29","author":"Endocrinology Branch of Chinese Medical Association","year":"2013","journal-title":"Chin J Endocrinol Metab"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.5.1245"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2215"},{"key":"CIT0021","unstructured":"US Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for industry. Diabetes mellitus: developing drugs and therapeutic biologics for treatment and prevention. 2008. [cited 2021 Feb 12]. Available from: https:\/\/docplayer.net\/5967402-Guidance-for-industry-diabetes-mellitus-developing-drugs-and-therapeutic-biologics-for-treatment-and-prevention.html."},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-S008"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2012.08.002"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2015.09.019"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2014.08.024"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2003.01010.x"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2005.05.015"},{"issue":"4","key":"CIT0028","first-page":"357","volume":"37","author":"Cucinotta D","year":"2012","journal-title":"Minerva Endocrinol"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1177\/1932296815605337"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2019-001410"},{"key":"CIT0031","unstructured":"European Medicines Agency. Insulin lispro Sanofi: summary of product characteristics. [cited 2020 Aug 26]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/insulin-lispro-sanofi-epar-product-information_en.pdf2017."},{"key":"CIT0032","unstructured":"U.S. Food and Drug Administration. ADMELOG: Full Prescribing Information. [cited 2020 Aug 26]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/209196s000lbl.pdf2017."},{"key":"CIT0033","unstructured":"European Medicines Agency. Insulin aspart Sanofi: summary of product information. [cited 2020 Aug 26]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/insulin-aspart-sanofi-epar-product-information_en.pdf2020."},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0382"},{"key":"CIT0035","unstructured":"European Medicines Agency. Clinical investigation of medicinal products in the treatment of diabetes mellitus, draft January 2018 [cited 2021 Feb 12]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-guideline-clinical-investigation-medicinal-products-treatment-prevention-diabetes-mellitus_en.pdf."},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0009"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4557-7"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12955"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200304100-00001"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2011.00767.x"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.5.876"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05415-0"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2022.2100652","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T06:17:29Z","timestamp":1670653049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2022.2100652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,2]]}},"alternative-id":["10.1080\/03007995.2022.2100652"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2022.2100652","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-03-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}